111 related articles for article (PubMed ID: 22046786)
1. [Metabolic syndrome in HIV-infected patients with favorable response to antiretroviral therapy].
Prisicăriu LJ; Dorobat CM; Manciuc C; Nicolau IC
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):776-80. PubMed ID: 22046786
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and clinical correlates of metabolic syndrome in Nigerians living with human immunodeficiency virus/acquired immunodeficiency syndrome.
Ayodele OE; Akinboro AO; Akinyemi SO; Adepeju AA; Akinremi OA; Alao CA; Popoola AA
Metab Syndr Relat Disord; 2012 Oct; 10(5):373-9. PubMed ID: 22799758
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome in French HIV-infected patients: prevalence and predictive factors after 3 years of antiretroviral therapy.
Biron A; Bobin-Dubigeon C; Volteau C; Piroth L; Perré P; Leport C; Prazuck T; Jovelin T; Billard M; Sébille V; Bard JM; Raffi F; Biron C
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1672-8. PubMed ID: 22731114
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of metabolic syndrome among human immunodeficiency virus-infected subjects is widely influenced by the diagnostic criteria.
Cubero JM; Domingo P; Sambeat M; Ordoñez-Llanos J; Rodriguez-Espinosa J; Sánchez-Quesada JL; Pérez A
Metab Syndr Relat Disord; 2011 Oct; 9(5):345-51. PubMed ID: 21542770
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population.
Mondy K; Overton ET; Grubb J; Tong S; Seyfried W; Powderly W; Yarasheski K
Clin Infect Dis; 2007 Mar; 44(5):726-34. PubMed ID: 17278068
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Metabolic Syndrome in Patients with HIV in the Era of Highly Active Antiretroviral Therapy.
Lombo B; Alkhalil I; Golden MP; Fotjadhi I; Ravi S; Virata M; Lievano M; Diez J; Ghantous A; Donohue T
Conn Med; 2015 May; 79(5):277-81. PubMed ID: 26245015
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of metabolic syndrome in Danish patients with HIV infection: the effect of antiretroviral therapy.
Hansen BR; Petersen J; Haugaard SB; Madsbad S; Obel N; Suzuki Y; Andersen O
HIV Med; 2009 Jul; 10(6):378-87. PubMed ID: 19490178
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
Jantarapakde J; Phanuphak N; Chaturawit C; Pengnonyang S; Mathajittiphan P; Takamtha P; Dungjun N; Pinyakorn S; Pima W; Prasithsirikul W; Phanuphak P
AIDS Patient Care STDS; 2014 Jul; 28(7):331-40. PubMed ID: 24914459
[TBL] [Abstract][Full Text] [Related]
10. Independent predictors of metabolic syndrome in HIV-infected patients.
Alencastro PR; Fuchs SC; Wolff FH; Ikeda ML; Brandão AB; Barcellos NT
AIDS Patient Care STDS; 2011 Nov; 25(11):627-34. PubMed ID: 21936688
[TBL] [Abstract][Full Text] [Related]
11. Burden of metabolic syndrome among HIV-infected patients in Southern Ethiopia.
Tesfaye DY; Kinde S; Medhin G; Megerssa YC; Tadewos A; Tadesse E; Shimelis T
Diabetes Metab Syndr; 2014; 8(2):102-7. PubMed ID: 24907175
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
Feleke Y; Fekade D; Mezegebu Y
Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
[TBL] [Abstract][Full Text] [Related]
13. Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon.
Nsagha DS; Weledji EP; Assob NJ; Njunda LA; Tanue EA; Kibu OD; Ayima CW; Ngowe MN
BMC Cardiovasc Disord; 2015 Aug; 15():95. PubMed ID: 26315756
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome in HIV-infected patients: no different than the general population?
Jones CY
Clin Infect Dis; 2007 Mar; 44(5):735-8. PubMed ID: 17278069
[No Abstract] [Full Text] [Related]
15. Metabolic syndrome in older HIV-infected patients: data from the CORE50 cohort.
Adeyemi O; Rezai K; Bahk M; Badri S; Thomas-Gossain N
AIDS Patient Care STDS; 2008 Dec; 22(12):941-5. PubMed ID: 19072100
[TBL] [Abstract][Full Text] [Related]
16. Incidence and prevalence of the metabolic syndrome in a cohort of naive HIV-infected patients: prospective analysis at 48 weeks of highly active antiretroviral therapy.
Palacios R; Santos J; González M; Ruiz J; Márquez M
Int J STD AIDS; 2007 Mar; 18(3):184-7. PubMed ID: 17362552
[TBL] [Abstract][Full Text] [Related]
17. The assessment of metabolic syndrome in UK patients with HIV using two different definitions: CREATE 2 study.
Elgalib A; Aboud M; Kulasegaram R; Dimian C; Duncan A; Wierzbicki AS; Peters BS
Curr Med Res Opin; 2011 Jan; 27(1):63-9. PubMed ID: 21091096
[TBL] [Abstract][Full Text] [Related]
18. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China.
Zhang L; Huang Y; Liu Z; Liu W; Qin Q; Tao R
J Med Virol; 2015 Jul; 87(7):1158-67. PubMed ID: 25777553
[TBL] [Abstract][Full Text] [Related]
20. Features of Metabolic Syndrome and Its Associated Factors during Highly Active Antiretroviral Therapy in Ouagadougou (Burkina Faso).
Guira O; Tiéno H; Diendéré AE; Sagna Y; Diallo I; Yaméogo B; Zoungrana L; Yaméogo TM; Bognounou R; Drabo JY
J Int Assoc Provid AIDS Care; 2016; 15(2):159-63. PubMed ID: 26307211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
